Literature DB >> 32013669

Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy.

Ruifang Wang1,2, Yinxing Zhu1,2, Chenwei Ren1,2, Shuaike Yang1,2, Shan Tian1,2, Huanchun Chen1,2, Meilin Jin1,2, Hongbo Zhou1,2.   

Abstract

Influenza A virus (IAV) infection induces mitophagy, which is essential for the clearance of damaged mitochondria. Dysfunctional mitochondria can be selectively targeted by PINK1, which recruits PRKN/PARK2 and leads to subsequent mitochondrial sequestration within autophagosomes. The IAV PB1-F2 protein translocates to mitochondria, accelerates the mitochondrial fragmentation and impairs the innate immunity. However, whether PB1-F2 mediates IAV-induced mitophagy and the relation between mitophagy and PB1-F2-attenuated innate immunity remain obscure. Here, we showed that PB1-F2 translocated to mitochondria by interacting and colocalizing with TUFM (Tu translation elongation factor, mitochondrial). Further studies revealed that PB1-F2 induced complete mitophagy, which required the interactions of PB1-F2 with both TUFM and MAP1LC3B/LC3B that mediated the autophagosome formation. PB1-F2-induced mitophagy was critical for the MAVS (mitochondrial antiviral signaling protein) degradation and led to its suppression of the type I IFN production. Importantly, the C-terminal LIR motif of PB1-F2 protein was demonstrated to be essential for its mitophagy induction and attenuated innate immunity. In conclusion, PB1-F2-induced mitophagy strongly correlates with impaired cellular innate immunity, revealing it is a potential therapeutic target.Abbreviations: BCL2L13: BCL2 like 13; BECN1: beclin 1; BNIP3L/Nix: BCL2 interacting protein 3 like; CQ: chloroquine; DDX58: DExD/H-box helicase 58; eGFP: enhanced green fluorescent protein; hpi: hours post infection; IAV: influenza A virus; IFN: interferon; IP: immunoprecipitation; LIR: LC3-interacting region; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MAVS: mitochondrial antiviral signaling protein; MMP: mitochondrial membrane potential; MOI, multiplicity of infection; mRFP: monomeric red fluorescent protein; NBR1: NBR1 autophagy cargo receptor; NC: negative control; NLRP3: NLR family pyrin domain containing 3; PINK1: PTEN induced kinase 1; PRKN/PARK2: parkin RBR E3 ubiquitin protein ligase; RLR: RIG-I-like-receptor; ROS: reactive oxygen species; SEV: sendai virus; SQSTM1/p62: sequestosome 1; TAX1BP1: Tax1 binding protein 1; TM: transmembrane; TOMM20/40: translocase of outer mitochondrial membrane 20/40; TUFM: Tu translation elongation factor, mitochondrial.

Entities:  

Keywords:  Influenza PB1-F2 protein; LC3b; MAVS; TUFM; innate immunity; mitophagy

Year:  2020        PMID: 32013669      PMCID: PMC8007153          DOI: 10.1080/15548627.2020.1725375

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  75 in total

1.  The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function.

Authors:  James S Gibbs; Daniela Malide; Felicita Hornung; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 2.  Mechanisms of mitophagy.

Authors:  Richard J Youle; Derek P Narendra
Journal:  Nat Rev Mol Cell Biol       Date:  2011-01       Impact factor: 94.444

Review 3.  [Role of mitophagy in the mitochondrial quality control].

Authors:  Pierre Vigié; Nadine Camougrand
Journal:  Med Sci (Paris)       Date:  2017-04-03       Impact factor: 0.818

4.  Influenza virus evades innate and adaptive immunity via the NS1 protein.

Authors:  Ana Fernandez-Sesma; Svetlana Marukian; Barbara J Ebersole; Dorothy Kaminski; Man-Seong Park; Tony Yuen; Stuart C Sealfon; Adolfo García-Sastre; Thomas M Moran
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential.

Authors:  Zsuzsanna T Varga; Alesha Grant; Balaji Manicassamy; Peter Palese
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

6.  Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens.

Authors:  Jenni N Weeks-Gorospe; Heather R Hurtig; Amy R Iverson; Margaret J Schuneman; Richard J Webby; Jonathan A McCullers; Victor C Huber
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

7.  Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu.

Authors:  Lucia Valente; Valeria Tiranti; Rene Massimiliano Marsano; Edoardo Malfatti; Erika Fernandez-Vizarra; Claudia Donnini; Paolo Mereghetti; Luca De Gioia; Alberto Burlina; Claudio Castellan; Giacomo P Comi; Salvatore Savasta; Iliana Ferrero; Massimo Zeviani
Journal:  Am J Hum Genet       Date:  2006-11-15       Impact factor: 11.025

8.  Genetic characterization of an H5N1 avian influenza virus with neurovirulence in ducks.

Authors:  Wei Zou; Zhengjun Yu; Hongbo Zhou; Jiagang Tu; Meilin Jin
Journal:  Virus Genes       Date:  2009-01-10       Impact factor: 2.332

Review 9.  Mitochondrial dynamics and mitochondrial quality control.

Authors:  Hong-Min Ni; Jessica A Williams; Wen-Xing Ding
Journal:  Redox Biol       Date:  2014-11-20       Impact factor: 11.799

10.  Hepatitis C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy.

Authors:  Seong-Jun Kim; Gulam H Syed; Aleem Siddiqui
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

View more
  27 in total

Review 1.  Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses.

Authors:  Hongnuan Wang; Wei Li; Shijun J Zheng
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

2.  Clinical assessment and molecular mechanism of the upregulation of Toll-like receptor 2 (TLR2) in myocardial infarction.

Authors:  Ming-Jie Li; Shi-Bai Yan; Hao Dong; Zhi-Guang Huang; Dong-Ming Li; Yu-Lu Tang; Yan-Fang Pan; Zhen Yang; Hong-Bo Pan; Gang Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-07-15       Impact factor: 2.174

Review 3.  Morphology Remodeling and Selective Autophagy of Intracellular Organelles during Viral Infections.

Authors:  Shanhui Ren; Chan Ding; Yingjie Sun
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 4.  Development and application of reverse genetic technology for the influenza virus.

Authors:  Ziquan Li; Liping Zhong; Jian He; Yong Huang; Yongxiang Zhao
Journal:  Virus Genes       Date:  2021-02-02       Impact factor: 2.332

Review 5.  Viral Infection Modulates Mitochondrial Function.

Authors:  Xiaowen Li; Keke Wu; Sen Zeng; Feifan Zhao; Jindai Fan; Zhaoyao Li; Lin Yi; Hongxing Ding; Mingqiu Zhao; Shuangqi Fan; Jinding Chen
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

6.  LDHB inhibition induces mitophagy and facilitates the progression of CSFV infection.

Authors:  Shuangqi Fan; Keke Wu; Mingqiu Zhao; Jin Yuan; Shengming Ma; Erpeng Zhu; Yuming Chen; Hongxing Ding; Lin Yi; Jinding Chen
Journal:  Autophagy       Date:  2020-09-28       Impact factor: 16.016

Review 7.  Herpesvirus Regulation of Selective Autophagy.

Authors:  Mai Tram Vo; Young Bong Choi
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

Review 8.  Host-Virus Interaction: How Host Cells Defend against Influenza A Virus Infection.

Authors:  Yun Zhang; Zhichao Xu; Yongchang Cao
Journal:  Viruses       Date:  2020-03-29       Impact factor: 5.048

Review 9.  Regulation of Innate Immune Responses by Autophagy: A Goldmine for Viruses.

Authors:  Baptiste Pradel; Véronique Robert-Hebmann; Lucile Espert
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

10.  CVB3-Mediated Mitophagy Plays an Important Role in Viral Replication via Abrogation of Interferon Pathways.

Authors:  Soo-Jin Oh; Byung-Kwan Lim; Jeanho Yun; Ok Sarah Shin
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.